Prevalence of Fabry disease in female patients with late-onset hypertrophic cardiomyopathy

Circulation

Volumn 110, Issue 9, 2004, Pages 1047-1053

  Chimenti, Cristina ^a   Pieroni, Maurizio ^a   Morgante, Emanuela ^b   Antuzzi, Daniela ^c   Russo, Andrea ^d   Russo, Matteo Antonio ^b   Maseri, Attilio ^a   Frustaci, Andrea ^c  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

^d UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Biopsy; Cardiomyopathy; Hypertrophy

Indexed keywords

ALPHA GALACTOSIDASE; GLYCOLIPID;

ADULT; APICAL HYPERTROPHY; ARTICLE; ASYMMETRIC HYPERTROPHY; CELL VACUOLE; CLINICAL ARTICLE; CONCENTRIC HYPERTROPHY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; ELECTRON MICROSCOPY; ENZYME ACTIVITY; FABRY DISEASE; FAMILY HISTORY; FEMALE; GENE MUTATION; GENETIC ANALYSIS; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE BIOPSY; HETEROZYGOTE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERTROPHIC CARDIOMYOPATHY; LATE ONSET HYPERTROPHIC CARDIOMYOPATHY; LIPID STORAGE; ONSET AGE; PEDIGREE; PRIORITY JOURNAL; X CHROMOSOME RECESSIVE DISORDER;

ADULT; AGE OF ONSET; AGED; ALPHA-GALACTOSIDASE; BIOPSY; CARDIOMYOPATHY, HYPERTROPHIC; DNA MUTATIONAL ANALYSIS; ELECTROCARDIOGRAPHY; ENDOCARDIUM; FABRY DISEASE; FEMALE; GENOTYPE; GLYCOLIPIDS; HETEROZYGOTE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; LYSOSOMES; MALE; MIDDLE AGED; PEDIGREE; PREVALENCE; VACUOLES;

EID: 4544344055     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000139847.74101.03     Document Type: Article

References (18)

1. Desnick RJ, Ioannou YA, Eng CM. α-Galactosidase A deficiency: Fabry disease. In: Scriver CR, Beaudet AL, Sly WS, et al, eds. The Metabolic and Molecular Bases of Inherited Disease. New York, NY: McGraw-Hill; 2001:3733-3774.
2. Nakao S, Takenaka T, Maeda M, et al. An atypical variant of Fabry's disease in men with left ventricular hypertrophy. N Engl J Med. 1995; 333:288-293.
3. Sachdev B, Takenaka T, Teraguchi H, et al. Prevalence of Anderson-Fabry disease in male patients with late-onset hypertrophic cardiomyopathy. Circulation. 2002;105:1407-1411.
4. Kampmann C, Baehner F, Whybra A, et al. Cardiac manifestations of Anderson-Fabry disease in heterozygous females. J Am Coll Cardiol. 2002;40:1668-1674.
5. Eng CM, Guffon N, Wilcox WR, et al. Safety and efficacy of recombinant human alpha-galactosidase A replacement therapy in Fabry's disease. N Engl J Med. 2001;345:9-16.
6. Frustaci A, Chimenti C, Ricci R, et al. Improvement in cardiac function in the cardiac variant of Fabry's disease with galactose-infusion therapy. N Engl J Med. 2001;345:25-32.
7. Maron BJ. Hypertrophic cardiomyopathy: a systematic review. JAMA. 2002;287:1308-1320.
8. Pieroni M, Chimenti C, Ricci R, et al. Early detection of Fabry cardiomyopathy by tissue Doppler imaging. Circulation. 2003;107:1978-1984.
9. Maron BJ, Gottdiener JS, Epstein SE. Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: a wide angle, two dimensional echocardiographic study of 125 patients. Am J Cardiol. 1981;48:418-428.
10. Gubler MC, Lenoir G, Grunfeld JP, et al. Early renal changes in hemizygous and heterozygous patients with Fabry's disease. Kidney Int. 1978; 13:223-235.
11. MacDermot KD, Holmes A, Miners AH. Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females. J Med Genet. 2001;38:769-775.
12. Doi Y, Toda G, Yano K. Sisters with atypical Fabry's disease with complete atrioventricular block. Heart. 2003;89:e2.
13. Carter N, Milroy CM, Shepherd RT. Sudden death in elderly women with Fabry's disease. Am J Forensic Med Pathol. 1995;16:21-26.
14. Romeo G, Migeon BR. Genetic activation of the α-galactosidase locus in carriers of Fabry's disease. Science. 1970;170:180-181.
15. Lyon MF. X-chromosome inactivation and human genetic disease. Acta Paediatr Suppl. 2002;439:107-112.
16. Sharp A, Robinson D, Jacobs P. Age and tissue-specific variation of X chromosome inactivation ratios in normal women. Hum Genet. 2000;107: 343-349.
17. Redonnet-Vernhet I, Ploos van Amstel JK, Jansen RP, et al. Uneven X inactivation in a female monozygotic twin pair with Fabry disease and discordant expression of a novel mutation in the α-galactosidase A gene. J Med Genet. 1996;33:682-688.
18. Weidemann F, Breunig F, Beer M, et al. Improvement of cardiac function during enzyme replacement therapy in patients with Fabry disease: a prospective strain rate imaging study. Circulation. 2003; 108:1299-1301.